Novartis AG (NVS) vs Invesco QQQ Trust, Series 1 (QQQ)
Over the past 10 years, NVS lagged QQQ — 11.99% vs 20.94% annualized total return (price plus dividends).
A side-by-side comparison of Novartis AG and Invesco QQQ Trust, Series 1 across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
Total return — NVS vs QQQ
growth of $100 · dividends reinvested · last 10yMetrics side by side
Did NVS beat QQQ?
Over the past 10 years, NVS lagged QQQ — 11.99% vs 20.94% annualized total return (price plus dividends).
Total return (annualized)
| Metric | NVS | QQQ |
|---|---|---|
| Total return (1Y) | 10.35% | 23.60% |
| Total return CAGR (3Y) | 17.25% | 28.12% |
| Total return CAGR (5Y) | 16.96% | 16.24% |
| Total return CAGR (10Y) | 11.99% | 20.94% |
QQQ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has NVS beaten QQQ?
- Over the past 10 years, NVS lagged QQQ — 11.99% vs 20.94% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.